[go: up one dir, main page]

AU2022597A - A method of treating disorders related to cytokines in mammals - Google Patents

A method of treating disorders related to cytokines in mammals

Info

Publication number
AU2022597A
AU2022597A AU20225/97A AU2022597A AU2022597A AU 2022597 A AU2022597 A AU 2022597A AU 20225/97 A AU20225/97 A AU 20225/97A AU 2022597 A AU2022597 A AU 2022597A AU 2022597 A AU2022597 A AU 2022597A
Authority
AU
Australia
Prior art keywords
cytokines
mammals
disorders related
treating disorders
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20225/97A
Inventor
Andrew Neil Bowler
Lars Knutsen
Uffe Bang Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2022597A publication Critical patent/AU2022597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU20225/97A 1996-03-13 1997-03-12 A method of treating disorders related to cytokines in mammals Abandoned AU2022597A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK29396 1996-03-13
DK293/96 1996-03-13
DK59196 1996-05-21
DK591/96 1996-05-21
PCT/DK1997/000108 WO1997033591A1 (en) 1996-03-13 1997-03-12 A method of treating disorders related to cytokines in mammals

Publications (1)

Publication Number Publication Date
AU2022597A true AU2022597A (en) 1997-10-01

Family

ID=26063711

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20225/97A Abandoned AU2022597A (en) 1996-03-13 1997-03-12 A method of treating disorders related to cytokines in mammals

Country Status (2)

Country Link
AU (1) AU2022597A (en)
WO (1) WO1997033591A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9610031D0 (en) * 1996-05-14 1996-07-17 Glaxo Group Ltd Chemical compounds
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723566D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723590D0 (en) 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB2372742A (en) 2001-03-03 2002-09-04 Univ Leiden C2,5'-Disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and their different uses
US7342003B2 (en) 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US7265111B2 (en) 2002-06-27 2007-09-04 Sanofi-Aventis Deutschland Gmbh Adenosine analogues and their use as pharmaceutical agents
EP1375508A1 (en) * 2002-06-27 2004-01-02 Aventis Pharma Deutschland GmbH N6-substituted adenosine analogues and their use as pharmaceutical agents
KR20050067384A (en) 2002-08-15 2005-07-01 씨브이 쎄러퓨틱스, 인코포레이티드 Partial and full agonists of a1 adenosine receptors
WO2005033121A2 (en) * 2003-10-03 2005-04-14 King Pharmaceuticals Research & Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
AU2023393410A1 (en) 2022-12-16 2025-07-31 Astrazeneca Ab 2,6,9-trisubstituted purines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003147A1 (en) * 1986-10-31 1988-05-05 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
ZA916464B (en) * 1990-08-22 1992-05-27 Merrell Dow Pharma 5'-amine substituted adenosine analogs as immunosuppressants
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
DK62592D0 (en) * 1992-05-14 1992-05-14 Novo Nordisk As
AU683287B2 (en) * 1993-07-23 1997-11-06 Merrell Pharmaceuticals Inc. Novel 9-N-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives

Also Published As

Publication number Publication date
WO1997033591A1 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
AU4880197A (en) Method for treatment of dermatological disorders
AU1994495A (en) Method of analyzing sleep disorders
AU6104096A (en) In-line skate conversion apparatus
AU1803195A (en) Method of manufacutring fibreboard and fibreboard produced thereby
AU2808997A (en) Method for treating inflammation
GB9620412D0 (en) A method of treating a laminate
AU2022597A (en) A method of treating disorders related to cytokines in mammals
AU7873594A (en) Method for refinishing wood
AU2022497A (en) A method of treating disorders related to cytokines in mammals
AU1317000A (en) Method of treating immunological disorders mediated by t-lymphocytes
IL135659A0 (en) Method of reducing craving in mammals
AU2251897A (en) Method of treating liver disorders
AU4794997A (en) Method for production of feed for salmonides and feed for salmonides
AU4554997A (en) Method of producing screw connections
HK1007046A1 (en) Method of treatment for eiph in racing stock
HK1007046B (en) Method of treatment for eiph in racing stock
EP0720375A3 (en) Quantizing apparatus and quantizing method
AU4027097A (en) Method of treatment
ZA972190B (en) A method of treating disorders related to cytokines in mammals.
AUPO439396A0 (en) A method of treatment and prophylaxis
AU1311195A (en) A method of treating neurogenic inflammation
AU3989995A (en) Method of treating membranes
AUPN991196A0 (en) A method of treating mammals
AUPO001996A0 (en) A method of treating mammals
AU2269392A (en) Method for treating immunological disorders and diseases